Skip to content
healthcare.dev

Topiramate

NDC 70748-278, Topiramate, capsule, extended release, from Lupin Pharmaceuticals, Inc..

Product NDC
70748-278
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215561
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70748-278 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
70748-278-067074802780630 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-278-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e310afcd-1260-434e-a994-34549c789d99
  • NADAC price for package 70748027806

    GET /v1/drugs/nadac/70748027806

Use it

Look up 70748-278 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70748-278 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70748-278. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.